131I Radioconjugated Antibodies for the Locoregional Radioimmunotherapy of High-grade Malignant Glioma: Phase I and II Study

By Riva Pietro   Franceschi Giancarlo   Frattarelli Massimo   Riva Nada   Guiducci Graziano   Cremonini Anna Maria   Giuliani Graziano   Casi Michela   Gentile Rossella   Jekunen Annti A.   Kairemo Kalevi J. A.  

Acta Oncologica, Vol. 38, Iss. 3, 1999-05 ,pp. : 351-359

Informa Healthcare

Access to resources Recommend Favorite

Monte Carlo single-cell dosimetry of I-131, I-125 and I-123 for targeted radioimmunotherapy of B-cell lymphoma

By Bousis Christos   Emfietzoglou Dimitris   Nikjoo Hooshang  

International Journal of Radiation Biology, Vol. 88, Iss. 12, 2012-12 ,pp. : 908-915

Informa Healthcare

Access to resources Recommend Favorite

Incidence and Risk of Thromboembolism During Treatment of High-grade Gliomas: a Prospective Study

By Brandes A.A.   Scelzi E.   Salmistraro G.   Ermani M.   Carollo C.   Berti F.   Zampieri P.   Baiocchi C.   Fiorentino M.V.  

European Journal of Cancer, Vol. 33, Iss. 10, 1997-09 ,pp. : 1592-1596

Elsevier

Access to resources Recommend Favorite

MTH-68/H Oncolytic Viral Treatment in Human High-Grade Gliomas

By Csatary L.K.   Gosztonyi G.   Szeberenyi J.   Fabian Z.   Liszka V.   Bodey B.   Csatary C.M.  

Journal of Neuro-Oncology, Vol. 67, Iss. 1-2, 2004-03 ,pp. : 83-93

Springer Publishing Company

Access to resources Recommend Favorite

Differences in the Expression Pattern of P-Glycoprotein and MRP1 in Low-Grade and High-Grade Gliomas

By de Faria Giselle Pinto   de Oliveira Jose Antonio   de Oliveira Jose Gustavo Pugliese   Romano Sergio de Oliveira   Neto Vivaldo Moura   Maia Raquel Ciuvalschi  

Cancer Investigation, Vol. 26, Iss. 9, 2008-11 ,pp. : 883-889

Informa Healthcare

Access to resources Recommend Favorite